Recent studies based on original retrospective analysis of digitalis use in breast cancer patients have demonstrated the anticancer effect of cardiac glycosides5 that directly inhibit Na+/K+-ATPase (NKA) activity. The gene discussed is TAC1; the disease is breast carcinoma.